JPET #58206 4
Selective serotonin reuptake inhibitors (SSRIs) were initially introduced as antidepressants and their potential as anxiolytics has been observed in the treatment of social phobia, post-traumatic stress disorder (PTSD), and generalized anxiety disorder (GAD) (e.g., Nutt et al., 1999) . While each of the SSRIs increases extracellular serotonin in the brain by blocking the 5-HT transporter (SERT), they differ substantially in terms of their selectivity (Nutt et al., 1999; Owens et al., 2001; Sánchez et al., 2003) . Actions at other binding sites, such as the muscarinic, histamine, adrenergic, and 5-HT 2 receptors, may contribute to some of the side effects commonly associated with SSRI treatment.
Though in general, these side effects are better tolerated than those from tricyclics and benzodiazepines, they are a limitation in the use of SSRIs.
Citalopram and its S-enantiomer, escitalopram (Lexapro ® or Cipralex ® ), are highly selective inhibitors of the SERT with low or no binding to 144 other receptors (Owens et al., 2001; Sánchez et al., 2003) . Compared to citalopram and its R-enantiomer, R-citalopram, escitalopram is at least 6-fold less potent in binding to the histamine 1 (H 1 )
receptor (Owens et al., 2001; Sánchez et al., 2003) . Escitalopram and citalopram have similar affinities for the sigma (σ 1 ) receptors, which are about 2-fold less than those of R-citalopram. Escitalopram is believed to confer the pharmacological effects of citalopram (Hyttel et al., 1992; Sánchez et al., 2003) and its effects can be inhibited by co-administration of R-citalopram (Sánchez, 2003a; Mørk et al., 2003) . In clinical reports, escitalopram has a faster onset of antidepressant effects compared to its racemate citalopram and has a low incidence of side effects (Montgomery et al., 2001; Burke et al., 2002; Wade et al., 2002; Waugh and Goa, 2003) .
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Preclinical research on the anxiolytic-like effects of SSRIs is variable; some studies find no effect of SSRIs, while others find decreases or increases in anxiety-like behaviors. A viable hypothesis for these SSRI effects depends on whether the particular experimental procedure measures conditioned or unconditioned behaviors particularly if the SSRI is given acutely (Miczek et al., 1995; Griebel, 1995) . One procedure that has consistently detected an anxiolytic-like effect of acutely administered SSRIs relies on the vocal responses of young rodents when they are briefly separated from their nest and their dam. Separated rodent pups emit ultrasonic vocalizations (USVs) in a frequency range between 30-80kHz that may serve as signals for the dam to initiate retrieval (Noirot, 1972; Brunelli et al., 1994) . The species-generality and unconditioned nature of vocal reactions distinguish them from many other preclinical measures of anxiety-like behaviors (Panksepp et al., 1980; Miczek et al., 1995; Sánchez, 2003b) .
Among the neurotransmitter systems that influence separation calling, GABA and 5-HT are particularly noteworthy. Anti-anxiety treatments such as benzodiazepines and 5-HT 1A agonists decrease calling, whereas benzodiazepine inverse agonists and pentylenetetrazol can increase calling (Gardner, 1985; Insel et al., 1986; Mos and Olivier, 1989; Winslow and Insel, 1991; Nastiti et al., 1991; Molewijk et al., 1996; Vivian et al., 1997; Fish et al., 2000) . Of the SSRIs, citalopram, fluoxetine, fluvoxamine, and paroxetine have been reported to reduce distress USVs (Mos and Olivier, 1989; Winslow and Insel, 1990; Olivier et al., 1998) . Similarly, these SSRIs, as well as escitalopram, reduce the shock-induced USVs of adult rats (Sánchez and Meier, 1997; Schreiber et al., 1998; Sánchez, 2003b; Sánchez et al., 2003) . Unlike the procedure in adult rats, the separation test can further be used to concurrently assess behavioral specificity, the This article has not been copyedited and formatted. The final version may differ from this version. (Vivian et al., 1997; Fish et al., 2000; Rowlett et al., 2001) . 5-HT 1A receptor agonists reduce both motor activity and calling at a similar dose-range, while 5-HT 1B receptor agonists reduce calling but stimulate motor activity (Fish et al., 2000) . While the doses of citalopram, fluvoxamine, and fluoxetine that reduce separation distress USVs, have not been reported to affect motor activity, a high dose of fluoxetine (20mg/kg) was reported to impair the negative geotaxis response in maternally separated rat pups (Mos and Olivier, 1989) The objective of the current study was to compare the anxiolytic-like and locomotor effects of escitalopram to those of other SSRIs and the serotonergic/noradrenergic reuptake inhibitor, venlafaxine in maternally separated 7-day old mouse pups. Pups of this age were selected because they emit the most separation USVs (Noirot, 1972; Fish et al., 2000; Branchi et al., 2001) . To further explore the mechanism through which escitalopram and citalopram reduce separation USVs, the interaction between escitalopram, R-citalopram, and the H 1 receptor antagonist pyrilamine were investigated.
This article has not been copyedited and formatted. The final version may differ from this version. Procedure. The test sessions were conducted between 0730 and 1930 hours and no differences in baseline USV rates were observed across different times of the day (Fish et al., 2000) . An entire litter of pups and some bedding were removed from the home cage, transported to the procedure room and maintained in an incubator (11.5 x 14 x 5 cm) at 34+ 1.0°C. Twenty minutes later, the pups were weighed, individually placed in the testing chamber for 30 seconds to screen for the emission of USVs, and marked for identification. The pups that vocalized more than 6 times (ca. 80%) were injected with either one dose of the drug or vehicle. After the injection, the lubricated thermo-probe was inserted about 7mm into the rectum and held in place until the temperature measurement stabilized (ca. 3sec). The pups were returned to the incubator for a specific interval (see drugs section) and a second rectal temperature was taken immediately before a 4 minute separation test. The signal detection software automatically counted USVs, Statistics. USV and grid crossing data (transformed into percent of vehicle), rolls and body temperatures (raw values) were analyzed using one-way between-subjects analysis of variance (ANOVA). F-values with p<0.05, were followed by post-hoc Dunnett's tests to determine which individual doses were significantly different from the vehicle This article has not been copyedited and formatted. The final version may differ from this version. Insert Figure 3 and Table 3 
Discussion
Several SSRIs and the selective noradrenergic reuptake inhibitor (SNRI) venlafaxine, reduced the maternal separation-induced USVs of mice and differed in terms of their potency and behavioral specificity. These results confirm earlier studies measuring USVs in neonatal rats after treatment with clinically effective anxiolytic drugs (Gardner, 1985; Mos and Olivier, 1989; Winslow and Insel, 1991; Olivier et al., 1998) Escitalopram was more potent than citalopram and R-citalopram at reducing separation USVs, a result that is similar to those from behavioral and in vitro binding studies (Hyttel et al., 1992; Owens et al., 2001; Burke et al., 2002; Sánchez et al., 2003) .
However, the magnitude of the potency difference, about 20 to 125 fold more than citalopram and R-citalopram, is larger than that predicted from the above studies. Based on SERT affinity, escitalopram should be about 2 fold more potent than citalopram and
clinically, escitalopram appears to be at least 2-fold more potent than citalopram (Burke et al., 2002) . Development of the 5-HT transporter system could have contributed to these discrepancies because the number and distribution of transporters substantially change with age (e.g., Lebrand et al., 1998) .
In addition to reducing USVs, all of the drugs altered motor behavior to varying degrees, as measured by grid crossing and rolling. Escitalopram and venlafaxine were This article has not been copyedited and formatted. The final version may differ from this version. (Table 4) The acute anxiolytic-like effects of the SSRIs on neonatal vocalizations (Mos and Olivier, 1989; Winslow and Insel, 1990; Molewijk et al., 1996; Olivier et al., 1998) differ from their acute effects in humans. In humans, the anxiolytic effects of SSRIs emerge only after chronic treatment and there are some reports that they may initially increase anxiety (for review, Nutt et al., 1999) . In preclinical studies, the acute effects of SSRIs can be detected in several procedures that are used for characterizing anxiolytic drugs but the nature of these effects varies markedly with the experimental procedure (for review, Griebel, 1995; Borsini et al., 2002) . Consistent anxiolytic-like effects of SSRIs occur on measures of footshock-induced USVs (Sánchez and Meier, 1997; Schreiber et al., 1998; Sánchez et al., 2003a) , burying behavior (Njung'e and Handley 1991), conditioned freezing (Hashimoto et al., 1996) , and increased movement across the electrified grids of the four plate test (Hascoet et al., 2000) . Anxiogenic-like effects of SSRIs have been observed on light-dark exploratory behavior (Sánchez and Meier, 1997) , noveltysuppressed feeding (Bodnoff et al., 1989) , the mouse defensive battery (Griebel, 1995) , social interaction test (File et al., 1999) and the elevated plus maze (File et al., 1999) .
Interpreting these contradictory results is difficult and it is clear that novel procedures for and dark box, it will be important to extend this assessment to several other procedures.
Procedures measuring vocalizations appear to be particularly sensitive to the acute anxiolytic-like effects of SSRIs but there are potentially confounding variables to consider (Winslow and Insel, 1991) . Young, developing animals may be differentially sensitive to drug treatments than are adults because of differences in number of receptors as well as pharmacokinetics (e.g., Lebrand et al., 1998; Gow et al., 2001 ). Manipulations of the 5-HT system in young animals could alter USVs by interfering with its role in ongoing neural development (e.g., Azmitia, 2001) . There is also some evidence that certain types of vocalizations in rat pups are influenced by variables such as respiration, thermoregulation, and heart rate (Sokoloff and Blumberg, 1997) , particularly after extended separation from the dam. Different neural microcircuits appear to subserve different kinds of vocalizations (Jürgens and Pratt, 1979; Covington and Miczek, 2003) .
Determining if these circuits are indeed the targets for the currently studied SSRIs could address whether the present results are significantly influenced by pharmacokinetic, developmental, or physiological variables.
Escitalopram is currently the most selective SSRI for inhibiting the SERT and its effects in mouse pups are consistent with its clinical efficacy in treating anxiety.
Although the maternal separation procedure appears to be particularly sensitive to detect the anxiolytic-like effects of SSRIs, it is important to examine escitalopram in other animal models of anxiety to assess the extent to which these results are species and age Table 3 .
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